Publications
- Newest First
- Most Cited
- Most Discussed
Showing 1 - 100 results of 11,830 publications
2024
- Cardiovascular Outcomes of KCNJ5 mutated Aldosterone-Producing Adenoma: A Systematic Review.Kato H, Kitamoto T, Kimura S, Sunouchi T, Hoshino Y, Hidaka N, Tsurutani Y, Ito N, Makita N, Nishikawa T, Nangaku M, Inoue K. Cardiovascular Outcomes of KCNJ5 mutated Aldosterone-Producing Adenoma: A Systematic Review. Endocr Pract 2024 PMID: 38657793, DOI: 10.1016/j.eprac.2024.04.007.
- Babesia duncani, A Model Organism for Investigating Intraerythrocytic Parasitism and Novel Anti-Parasitic Therapeutic Strategies.Fang T, Ben Mamoun C. Babesia duncani, A Model Organism for Investigating Intraerythrocytic Parasitism and Novel Anti-Parasitic Therapeutic Strategies. J Infect Dis 2024 PMID: 38626187, DOI: 10.1093/infdis/jiae191.
- Hyperbolic Diffusion Procrustes Analysis for Intrinsic Representation of Hierarchical Data SetsLin Y, Kluger Y, Talmon R. Hyperbolic Diffusion Procrustes Analysis for Intrinsic Representation of Hierarchical Data Sets. 2024, 6325-6329. DOI: 10.1109/icassp48485.2024.10446370.
- Heterozygous CDKN2A Loss is Associated with Recurrence and Survival in High, But Not Low Grade MeningiomasTabor J, O'Brien J, Valero S, Pappajohn A, McGuone D, Erson-Omay Z, Yasuno K, Gunel M, Moliterno J. Heterozygous CDKN2A Loss is Associated with Recurrence and Survival in High, But Not Low Grade Meningiomas. Neurosurgery 2024, 70: 203-203. DOI: 10.1227/neu.0000000000002810_112.
- Genetics of liver disease in adultsKonkwo C, Chowdhury S, Vilarinho S. Genetics of liver disease in adults. Hepatology Communications 2024, 8: e0408. PMID: 38551385, PMCID: PMC10984672, DOI: 10.1097/hc9.0000000000000408.
- TGFβ1 Drives Integrin Dependent Pericyte Migration and Microvascular Destabilization In Fibrotic DiseasePellowe A, Wu M, Kang T, Chung T, Ledesma-Mendoza A, Herzog E, Levchenko A, Odell I, Varga J, Gonzalez A. TGFβ1 Drives Integrin Dependent Pericyte Migration and Microvascular Destabilization In Fibrotic Disease. American Journal Of Pathology 2024 PMID: 38548268, DOI: 10.1016/j.ajpath.2024.02.021.
- TNF receptor-2 signals clear-cell renal carcinoma proliferation via phosphorylated-4EBP1 and mitochondrial gene translationAl-Lamki R, Tolkovsky A, Alawwami M, Lu W, Field S, Wang J, Pober J, Bradley J. TNF receptor-2 signals clear-cell renal carcinoma proliferation via phosphorylated-4EBP1 and mitochondrial gene translation. American Journal Of Pathology 2024 PMID: 38537932, DOI: 10.1016/j.ajpath.2024.02.019.
- Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscapeBoddu P, Gupta A, Roy R, De La Peña Avalos B, Olazabal-Herrero A, Neuenkirchen N, Zimmer J, Chandhok N, King D, Nannya Y, Ogawa S, Lin H, Simon M, Dray E, Kupfer G, Verma A, Neugebauer K, Pillai M. Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape. Molecular Cell 2024 PMID: 38521065, DOI: 10.1016/j.molcel.2024.02.032.
- Variations in the genomic profiles and clinical behavior of meningioma by racial and ethnic group.Tabor J, Dincer A, O'Brien J, Lei H, Vetsa S, Vasandani S, Jalal M, Yalcin K, Morales-Valero S, Marianayagam N, Alanya H, Elsamadicy A, Millares Chavez M, Aguilera S, Mishra-Gorur K, McGuone D, Fulbright R, Jin L, Erson-Omay E, Günel M, Moliterno J. Variations in the genomic profiles and clinical behavior of meningioma by racial and ethnic group. Journal Of Neurosurgery 2024, 1-9. PMID: 38518289, DOI: 10.3171/2024.1.jns231633.
- Abstract 1718: The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasisKravitz C, Patel K, Cai W, Arnal-Estapé A, Zhao D, Wingrove E, Stevens L, Westbrook T, Yan Q, Nguyen D. Abstract 1718: The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis. Cancer Research 2024, 84: 1718-1718. DOI: 10.1158/1538-7445.am2024-1718.
- Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4‐induced brain pathologyMiller B, Kim S, Cao K, Mehta H, Thumaty N, Kumagai H, Iida T, McGill C, Pike C, Nurmakova K, Levine Z, Sullivan P, Yen K, Ertekin‐Taner N, Atzmon G, Barzilai N, Cohen P. Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4‐induced brain pathology. Aging Cell 2024, e14153. PMID: 38520065, DOI: 10.1111/acel.14153.
- Abstract 4104: Randomized phase II trial of imiquimod with or without 9vHPV vs observation in patients with CIN 2 and 3Sheth S, Oh J, Bellone S, Siegel E, Buza N, Iwasaki A, Santin A. Abstract 4104: Randomized phase II trial of imiquimod with or without 9vHPV vs observation in patients with CIN 2 and 3. Cancer Research 2024, 84: 4104-4104. DOI: 10.1158/1538-7445.am2024-4104.
- Abstract 3086: NAPRT silencing in oncometabolite-producing cancers confers therapeutic vulnerabilities to NAD+ depletionNoronha K, Lucas K, Zhao S, Edmonds J, Friedman S, Murray M, Liu S, Liang J, Paradkar S, Zeng H, Sundaram R, Spurrier J, Raponi M, Sajed D, Shuch B, Vasquez J, Bindra R. Abstract 3086: NAPRT silencing in oncometabolite-producing cancers confers therapeutic vulnerabilities to NAD+ depletion. Cancer Research 2024, 84: 3086-3086. DOI: 10.1158/1538-7445.am2024-3086.
- Abstract 3632: Cytokine profiles associated with ICI myocarditis using machine learning approaches identifies novel cytokines and implicated pathwaysChehayeb R, Hong D, Chen N, Martinez C, Jayakrishnan R, Guajardo A, Lin D, Im Y, Halene S, VanOudenhove J, Hwa J, Jha A, Kwan J. Abstract 3632: Cytokine profiles associated with ICI myocarditis using machine learning approaches identifies novel cytokines and implicated pathways. Cancer Research 2024, 84: 3632-3632. DOI: 10.1158/1538-7445.am2024-3632.
- Abstract 7123: Biomarker-targeted alkylator and DNA damage repair inhibitor combination for refractory and relapsed acute myeloid leukemia (AML)Bhardwaj P, Sundaram R, Baassiri A, Matthews M, VanOudenhove J, Gueble S, Halene S, Bindra R. Abstract 7123: Biomarker-targeted alkylator and DNA damage repair inhibitor combination for refractory and relapsed acute myeloid leukemia (AML). Cancer Research 2024, 84: 7123-7123. DOI: 10.1158/1538-7445.am2024-7123.
- Abstract 4293: Chromosomal instability causes epigenetic aberrations in cancerAgustinus A, Al-Rawi D, Dameracharla B, Raviram R, Jones B, Stransky S, Scipioni L, Luebeck J, Bona M, Norkunaite D, Myers R, Duran M, Choi S, Weigelt B, Yomtoubian S, McPherson A, Toufektchan E, Keuper K, Mischel P, Mittal V, Shah S, Maciejowski J, Storchova Z, Gratton E, Ly P, Landau D, Bakhoum M, Koche R, Sidoli S, Bafna V, David Y, Bakhoum S. Abstract 4293: Chromosomal instability causes epigenetic aberrations in cancer. Cancer Research 2024, 84: 4293-4293. DOI: 10.1158/1538-7445.am2024-4293.
- Abstract 7117: Convection enhanced delivery of a novel ATR inhibitor synergizes with systemic lomustine for improved treatment of glioblastomaJosowitz A, Lee T, Sundaram R, Pothupitiya J, Brown E, Sule A, Beckta J, Wang Y, Vacca J, Gilad O, Bindra R, Saltzman W. Abstract 7117: Convection enhanced delivery of a novel ATR inhibitor synergizes with systemic lomustine for improved treatment of glioblastoma. Cancer Research 2024, 84: 7117-7117. DOI: 10.1158/1538-7445.am2024-7117.
- Abstract 101: A novel humanized mouse model recapitulates the unique TME found in patients with HIV-associated NSCLCJuric M, Kaufmann G, Zhu L, Ranjan K, Agrawal K, Rajendran B, Rajashekar J, Zhao H, Kluger Y, Emu B, Schalper K, Kumar P, Flavell R, Chiorazzi M. Abstract 101: A novel humanized mouse model recapitulates the unique TME found in patients with HIV-associated NSCLC. Cancer Research 2024, 84: 101-101. DOI: 10.1158/1538-7445.am2024-101.
- Abstract 2866: NAPRT silencing in rhabdomyosarcoma confers therapeutic vulnerabilities to NAD+depletionZhao S, Noronha K, Bhardwaj P, Lucas K, Sundaram R, Heer C, Morotti R, Spurrier J, Raponi M, Bindra R, Vasquez J. Abstract 2866: NAPRT silencing in rhabdomyosarcoma confers therapeutic vulnerabilities to NAD+depletion. Cancer Research 2024, 84: 2866-2866. DOI: 10.1158/1538-7445.am2024-2866.
- Abstract 1058: Immune biomarkers for recurrence in stage II and III melanoma to guide patient stratificationEspinoza G, Zhang C, Moon J, Kenchappa D, Abbruzzese M, Bioh L, Bracero Y, Sultana S, Singh A, Aung T, Krolewski J, Gartrell R, Geskin L, Leung L, Ferringer T, Chang R, Horst B, Nastiuk K, Saenger Y. Abstract 1058: Immune biomarkers for recurrence in stage II and III melanoma to guide patient stratification. Cancer Research 2024, 84: 1058-1058. DOI: 10.1158/1538-7445.am2024-1058.
- Abstract 6732: Immunomodulatory and anti-tumor effect of a CCR2-targeted STING agonist iADC in human lung cancerPorciuncula A, Appleman V, Parent A, Raizer J, Gregory R, Lineberry N, Abu-Yousif A, Schalper K. Abstract 6732: Immunomodulatory and anti-tumor effect of a CCR2-targeted STING agonist iADC in human lung cancer. Cancer Research 2024, 84: 6732-6732. DOI: 10.1158/1538-7445.am2024-6732.
- Abstract 5673: Transposable element expression patterns in epigenetic mutational subtypes of clear cell renal cell carcinomaMeli K, Ricker C, Camp S, Smith C, Labaki C, Saad E, Soulati H, Reardon B, Park J, Vokes N, Vincent B, Choueiri T, Braun D, Van Allen E. Abstract 5673: Transposable element expression patterns in epigenetic mutational subtypes of clear cell renal cell carcinoma. Cancer Research 2024, 84: 5673-5673. DOI: 10.1158/1538-7445.am2024-5673.
- Abstract 4893: Role of MGMT expression in the genomic landscape and immunogenicity in human colorectal carcinomasRajendran B, Zhang J, Desai S, Gibson J, DiPalermo J, LoRusso P, Kong Y, Zhao H, Cecchini M, Schalper K. Abstract 4893: Role of MGMT expression in the genomic landscape and immunogenicity in human colorectal carcinomas. Cancer Research 2024, 84: 4893-4893. DOI: 10.1158/1538-7445.am2024-4893.
- Abstract 1141: Spatial-specific gene signatures to predict immunotherapy outcomes in lung cancerAung T, Moutafi M, Trontzas I, Kulasinghe A, Monkman J, Gavrielatou N, Vathiotis I, Warrell J, Rimm D. Abstract 1141: Spatial-specific gene signatures to predict immunotherapy outcomes in lung cancer. Cancer Research 2024, 84: 1141-1141. DOI: 10.1158/1538-7445.am2024-1141.
- Impact of 18F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning–Generated BiomarkersHaider S, Zeevi T, Sharaf K, Gross M, Mahajan A, Kann B, Judson B, Prasad M, Burtness B, Aboian M, Canis M, Reichel C, Baumeister P, Payabvash S. Impact of 18F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning–Generated Biomarkers. Journal Of Nuclear Medicine 2024, jnumed.123.266637. PMID: 38514087, DOI: 10.2967/jnumed.123.266637.
- Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanomaSu D, Schoenfeld D, Ibrahim W, Cabrejo R, Djureinovic D, Baumann R, Rimm D, Khan S, Halaban R, Kluger H, Olino K, Galan A, Clune J. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal For ImmunoTherapy Of Cancer 2024, 12: e008646. PMID: 38519058, PMCID: PMC10961546, DOI: 10.1136/jitc-2023-008646.
- An immunophenotype-coupled transcriptomic atlas of human hematopoietic progenitorsZhang X, Song B, Carlino M, Li G, Ferchen K, Chen M, Thompson E, Kain B, Schnell D, Thakkar K, Kouril M, Jin K, Hay S, Sen S, Bernardicius D, Ma S, Bennett S, Croteau J, Salvatori O, Lye M, Gillen A, Jordan C, Singh H, Krause D, Salomonis N, Grimes H. An immunophenotype-coupled transcriptomic atlas of human hematopoietic progenitors. Nature Immunology 2024, 25: 703-715. PMID: 38514887, PMCID: PMC11003869, DOI: 10.1038/s41590-024-01782-4.
- The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 Cases.Fadare O, Fard E, Bhargava R, Desouki M, Hanley K, Ip P, Li J, Lu B, Medeiros F, Ng J, Parkash V, Pinto A, Quick C, Skala S, Tokuyama M, Turashvili G, Wei C, Xing D, Zheng W, Soong T, Howitt B. The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 Cases. The American Journal Of Surgical Pathology 2024 PMID: 38512100, DOI: 10.1097/pas.0000000000002201.
- Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guidelineKim J, Hwang K, Lee D, Kim S, Choi Y. Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline. Human Reproduction 2024, deae042. PMID: 38514450, DOI: 10.1093/humrep/deae042.
- Unique Spatial Transcriptomic Profiling of the Murine Femoral Fracture Callus: A Preliminary ReportJiang W, Caruana D, Back J, Lee F. Unique Spatial Transcriptomic Profiling of the Murine Femoral Fracture Callus: A Preliminary Report. Cells 2024, 13: 522. PMID: 38534368, PMCID: PMC10969736, DOI: 10.3390/cells13060522.
- Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritisMoledina D, Obeid W, Smith R, Rosales I, Sise M, Moeckel G, Kashgarian M, Kuperman M, Campbell K, Lefferts S, Meliambro K, Bitzer M, Perazella M, Luciano R, Pober J, Cantley L, Colvin R, Wilson F, Parikh C. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. Journal Of Clinical Investigation 2024, 134: e180583. PMID: 38488004, PMCID: PMC10940080, DOI: 10.1172/jci180583.
- A multi-omics systems vaccinology resource to develop and test computational models of immunityShinde P, Soldevila F, Reyna J, Aoki M, Rasmussen M, Willemsen L, Kojima M, Ha B, Greenbaum J, Overton J, Guzman-Orozco H, Nili S, Orfield S, Gygi J, da Silva Antunes R, Sette A, Grant B, Olsen L, Konstorum A, Guan L, Ay F, Kleinstein S, Peters B. A multi-omics systems vaccinology resource to develop and test computational models of immunity. Cell Reports Methods 2024, 4: 100731. PMID: 38490204, PMCID: PMC10985234, DOI: 10.1016/j.crmeth.2024.100731.
- Three-Dimensional Reconstruction Pre-Training as a Prior to Improve Robustness to Adversarial Attacks and Spurious CorrelationYamada Y, Zhang F, Kluger Y, Yildirim I. Three-Dimensional Reconstruction Pre-Training as a Prior to Improve Robustness to Adversarial Attacks and Spurious Correlation. Entropy 2024, 26: 258. PMID: 38539769, PMCID: PMC10968904, DOI: 10.3390/e26030258.
- MLL1 regulates cytokine-driven cell migration and metastasisNair P, Danilova L, Gómez-de-Mariscal E, Kim D, Fan R, Muñoz-Barrutia A, Fertig E, Wirtz D. MLL1 regulates cytokine-driven cell migration and metastasis. Science Advances 2024, 10: eadk0785. PMID: 38478601, PMCID: PMC10936879, DOI: 10.1126/sciadv.adk0785.
- Response to the Letter by Liu and ColleaguesMamoun C, Vydyam P. Response to the Letter by Liu and Colleagues. The Journal Of Infectious Diseases 2024, jiae084. PMID: 38471083, DOI: 10.1093/infdis/jiae084.
- Cellular Dynamics of Fas-Associated Death Domain in the Regulation of Cancer and InflammationRanjan K, Pathak C. Cellular Dynamics of Fas-Associated Death Domain in the Regulation of Cancer and Inflammation. International Journal Of Molecular Sciences 2024, 25: 3228. PMID: 38542202, PMCID: PMC10970579, DOI: 10.3390/ijms25063228.
- Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia.Ito N, Hidaka N, Kato H. Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia. Endocrinol Metab (Seoul) 2024 PMID: 38467164, DOI: 10.3803/EnM.2023.1908.
- Rational Design of TDP-43 Derived α‑Helical Peptide Inhibitors: An In Silico Strategy to Prevent TDP-43 Aggregation in Neurodegenerative DisordersSalaikumaran M, Gopal P. Rational Design of TDP-43 Derived α‑Helical Peptide Inhibitors: An In Silico Strategy to Prevent TDP-43 Aggregation in Neurodegenerative Disorders. ACS Chemical Neuroscience 2024, 15: 1096-1109. PMID: 38466778, PMCID: PMC10959110, DOI: 10.1021/acschemneuro.3c00659.
- microRNA-33 controls hunger signaling in hypothalamic AgRP neuronsPrice N, Fernández-Tussy P, Varela L, Cardelo M, Shanabrough M, Aryal B, de Cabo R, Suárez Y, Horvath T, Fernández-Hernando C. microRNA-33 controls hunger signaling in hypothalamic AgRP neurons. Nature Communications 2024, 15: 2131. PMID: 38459068, PMCID: PMC10923783, DOI: 10.1038/s41467-024-46427-0.
- Wnt5 controls splenic myelopoiesis and neutrophil functional ambivalency during DSS-induced colitisLuan Y, Hu J, Wang Q, Wang X, Li W, Qu R, Yang C, Rajendran B, Zhou H, Liu P, Zhang N, Shi Y, Liu Y, Tang W, Lu J, Wu D. Wnt5 controls splenic myelopoiesis and neutrophil functional ambivalency during DSS-induced colitis. Cell Reports 2024, 43: 113934. PMID: 38461416, DOI: 10.1016/j.celrep.2024.113934.
- Integrative Analysis of Germline Rare Variants in Clear and Non–clear Cell Renal Cell CarcinomaHan S, Camp S, Chu H, Collins R, Gillani R, Park J, Bakouny Z, Ricker C, Reardon B, Moore N, Kofman E, Labaki C, Braun D, Choueiri T, AlDubayan S, Van Allen E. Integrative Analysis of Germline Rare Variants in Clear and Non–clear Cell Renal Cell Carcinoma. European Urology Open Science 2024, 62: 107-122. PMID: 38496821, PMCID: PMC10940785, DOI: 10.1016/j.euros.2024.02.006.
- Improving diagnostic yield of pancreatic serous cystadenoma with cyst fluid ancillary testing, adjunct immunohistochemistry, and additional fine‐needle biopsy samplingWang X, Zhang X, Hui P, Cai G. Improving diagnostic yield of pancreatic serous cystadenoma with cyst fluid ancillary testing, adjunct immunohistochemistry, and additional fine‐needle biopsy sampling. Cancer Cytopathology 2024 PMID: 38450993, DOI: 10.1002/cncy.22808.
- Editorial: Modulation of the Immune System to Improve Tissue Regeneration StrategiesBracaglia L, Kyriakides T. Editorial: Modulation of the Immune System to Improve Tissue Regeneration Strategies. Tissue Engineering Part A 2024, 30: 257-258. PMID: 38451538, DOI: 10.1089/ten.tea.2024.29055.editorial.
- Author Correction: Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironmentsJaniszewska M, Tabassum D, Castaño Z, Cristea S, Yamamoto K, Kingston N, Murphy K, Shu S, Harper N, Del Alcazar C, Alečković M, Ekram M, Cohen O, Kwak M, Qin Y, Laszewski T, Luoma A, Marusyk A, Wucherpfennig K, Wagle N, Fan R, Michor F, McAllister S, Polyak K. Author Correction: Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments. Nature Cell Biology 2024, 1-1. PMID: 38443568, DOI: 10.1038/s41556-024-01385-z.
- Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancerRoque D, Siegel E, Buza N, Bellone S, Silasi D, Huang G, Andikyan V, Clark M, Azodi M, Schwartz P, Rao G, Reader J, Hui P, Tymon-Rosario J, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Santin A. Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer. British Journal Of Cancer 2024, 130: 1073-1073. PMID: 38438590, PMCID: PMC10951353, DOI: 10.1038/s41416-024-02628-4.
- Abstract P03: Splicing factor mutations induce stress granule upregulation in myeloid malignanciesBiancon G, Busarello E, Cheng M, Baccon D, VanOudenhove J, Ciceri F, Tebaldi T, Halene S. Abstract P03: Splicing factor mutations induce stress granule upregulation in myeloid malignancies. Blood Cancer Discovery 2024, 5: p03-p03. DOI: 10.1158/2643-3249.bcdsymp24-p03.
- Clinical outcomes of a canal-sparing shoulder arthroplasty system at a minimum of 2-year follow-upMoran J, Kahan J, Cheng R, Amaral J, Coxe F, Manzi J, Kunze K, Nicholson A, Jorgensen A, Ware J, Lee F, Blaine T. Clinical outcomes of a canal-sparing shoulder arthroplasty system at a minimum of 2-year follow-up. Seminars In Arthroplasty JSES 2024, 34: 203-208. DOI: 10.1053/j.sart.2023.10.006.
- Prolonged length of stay and omission of adjuvant therapy are associated with early mortality after pancreatic adenocarcinoma resectionYing L, Ilagan-Ying Y, Kunstman J, Peters N, Almeida M, Blackburn H, Ferrucci L, Billingsley K, Khan S, Chhoda A, John N, Salem R, Sharma A, Ahuja N. Prolonged length of stay and omission of adjuvant therapy are associated with early mortality after pancreatic adenocarcinoma resection. Surgical Oncology Insight 2024, 1: 100007. DOI: 10.1016/j.soi.2024.100007.
- How Efforts to Understand Somatic Mosaicism Will Impact DermatologyMortlock R, Choate K. How Efforts to Understand Somatic Mosaicism Will Impact Dermatology. Journal Of Investigative Dermatology 2024, 144: 453-455. PMID: 38395493, PMCID: PMC11009867, DOI: 10.1016/j.jid.2023.10.007.
- Syringotropic mycosis fungoides with clinical and histologic features of necrobiosis lipodica diabeticorumTorres-Piwinski M, Carlson K, Panse G, Girardi M. Syringotropic mycosis fungoides with clinical and histologic features of necrobiosis lipodica diabeticorum. JAAD Case Reports 2024 DOI: 10.1016/j.jdcr.2024.02.029.
- Changing Digital and Telecytology Practices post COVID-19 Comparing ASC survey results from 2016 to 2023Chen-Yost H, Bammert C, Hao W, Heymann J, Lin D, Marotti J, Waraksa-Deutsch T, Huang M, Krishnamurti U, Lin O, Ly A, Moatamed N, Pantanowitz L, Roy-Chowdhuri S. Changing Digital and Telecytology Practices post COVID-19 Comparing ASC survey results from 2016 to 2023. Journal Of The American Society Of Cytopathology 2024 PMID: 38582697, DOI: 10.1016/j.jasc.2024.02.004.
- IL-10 constrains sphingolipid metabolism to limit inflammationYork A, Skadow M, Oh J, Qu R, Zhou Q, Hsieh W, Mowel W, Brewer J, Kaffe E, Williams K, Kluger Y, Smale S, Crawford J, Bensinger S, Flavell R. IL-10 constrains sphingolipid metabolism to limit inflammation. Nature 2024, 627: 628-635. PMID: 38383790, PMCID: PMC10954550, DOI: 10.1038/s41586-024-07098-5.
- Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinomaKim I, Diamond M, Yuan S, Kemp S, Kahn B, Li Q, Lin J, Li J, Norgard R, Thomas S, Merolle M, Katsuda T, Tobias J, Baslan T, Politi K, Vonderheide R, Stanger B. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma. Nature Communications 2024, 15: 1532. PMID: 38378697, PMCID: PMC10879147, DOI: 10.1038/s41467-024-46048-7.
- Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease riskBrandhorst S, Levine M, Wei M, Shelehchi M, Morgan T, Nayak K, Dorff T, Hong K, Crimmins E, Cohen P, Longo V. Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk. Nature Communications 2024, 15: 1309. PMID: 38378685, PMCID: PMC10879164, DOI: 10.1038/s41467-024-45260-9.
- Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications.Nagy A, Niu N, Ratner E, Hui P, Buza N. Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications. International Journal Of Gynecological Pathology 2024 PMID: 38426544, DOI: 10.1097/pgp.0000000000001024.
- Cutaneous diatoms from diatomaceous earth mimicking myiasis infectionRoy S, Micevic G, McNiff J, Christensen S, Cowper S. Cutaneous diatoms from diatomaceous earth mimicking myiasis infection. Pathology 2024 PMID: 38471986, DOI: 10.1016/j.pathol.2023.12.416.
- Antitrypanosomal ChloronitrobenzamidesCarrillo A, Kadayat T, Hwang J, Chen Y, Zhu F, Holbrook G, Gillingwater K, Connelly M, Yang L, Kaiser M, Guy R. Antitrypanosomal Chloronitrobenzamides. Journal Of Medicinal Chemistry 2024, 67: 3437-3447. PMID: 38363074, DOI: 10.1021/acs.jmedchem.3c01680.
- ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.Hu B, Wiesehöfer M, de Miguel F, Liu Z, Chan L, Choi J, Melnick M, Arnal-Estape A, Walther Z, Zhao D, Lopez-Giraldez F, Wurtz A, Cai G, Fan R, Gettinger S, Xiao A, Yan Q, Homer R, Nguyen D, Politi K. ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer Research 2024, 84: 1303-1319. PMID: 38359163, DOI: 10.1158/0008-5472.can-23-0438.
- When lungs and weights tell different storiesGodse S, Brumer E, Kizilirmak T, Canapari C, Silva C, Morotti R, Jiang Y, Jeffries L, Chen L, Panacherry S. When lungs and weights tell different stories. Pediatric Pulmonology 2024, 59: 1047-1059. PMID: 38353400, DOI: 10.1002/ppul.26832.
- Validation of biomarkers of agingMoqri M, Herzog C, Poganik J, Ying K, Justice J, Belsky D, Higgins-Chen A, Chen B, Cohen A, Fuellen G, Hägg S, Marioni R, Widschwendter M, Fortney K, Fedichev P, Zhavoronkov A, Barzilai N, Lasky-Su J, Kiel D, Kennedy B, Cummings S, Slagboom P, Verdin E, Maier A, Sebastiano V, Snyder M, Gladyshev V, Horvath S, Ferrucci L. Validation of biomarkers of aging. Nature Medicine 2024, 30: 360-372. PMID: 38355974, DOI: 10.1038/s41591-023-02784-9.
- Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathwayPark A, Leney-Greene M, Lynberg M, Gabrielski J, Xu X, Schwarz B, Zheng L, Balasubramaniyam A, Ham H, Chao B, Zhang Y, Matthews H, Cui J, Yao Y, Kubo S, Chanchu J, Morawski A, Cook S, Jiang P, Ravell J, Cheng Y, George A, Faruqi A, Pagalilauan A, Bergerson J, Ganesan S, Chauvin S, Aluri J, Edwards-Hicks J, Bohrnsen E, Tippett C, Omar H, Xu L, Butcher G, Pascall J, Karakoc-Aydiner E, Kiykim A, Maecker H, Tezcan İ, Esenboga S, Heredia R, Akata D, Tekin S, Kara A, Kuloglu Z, Unal E, Kendirli T, Dogu F, Karabiber E, Atkinson T, Cochet C, Filhol O, Bosio C, Davis M, Lifton R, Pearce E, Daumke O, Aytekin C, Şahin G, Aksu A, Uzel G, Koneti Rao V, Sari S, Dalgıç B, Boztug K, Cagdas D, Haskologlu S, Ikinciogullari A, Schwefel D, Vilarinho S, Baris S, Ozen A, Su H, Lenardo M. Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway. Nature Immunology 2024, 25: 717-717. PMID: 38347083, DOI: 10.1038/s41590-024-01779-z.
- Heterogeneity of hepatocyte dynamics restores liver architecture after chemical, physical or viral damageRuz-Maldonado I, Gonzalez J, Zhang H, Sun J, Bort A, Kabir I, Kibbey R, Suárez Y, Greif D, Fernández-Hernando C. Heterogeneity of hepatocyte dynamics restores liver architecture after chemical, physical or viral damage. Nature Communications 2024, 15: 1247. PMID: 38341404, PMCID: PMC10858916, DOI: 10.1038/s41467-024-45439-0.
- CD23+IgG1+ memory B cells are poised to switch to pathogenic IgE production in food allergyOta M, Hoehn K, Fernandes-Braga W, Ota T, Aranda C, Friedman S, Miranda-Waldetario M, Redes J, Suprun M, Grishina G, Sampson H, Malbari A, Kleinstein S, Sicherer S, Curotto de Lafaille M. CD23+IgG1+ memory B cells are poised to switch to pathogenic IgE production in food allergy. Science Translational Medicine 2024, 16: eadi0673. PMID: 38324641, PMCID: PMC11008013, DOI: 10.1126/scitranslmed.adi0673.
- Novel muscle-derived extracellular matrix hydrogel promotes angiogenesis and neurogenesis in volumetric muscle lossChen Z, Huang Y, Xing H, Tseng T, Edelman H, Perry R, Kyriakides T. Novel muscle-derived extracellular matrix hydrogel promotes angiogenesis and neurogenesis in volumetric muscle loss. Matrix Biology 2024, 127: 38-47. PMID: 38325441, PMCID: PMC10958762, DOI: 10.1016/j.matbio.2024.02.001.
- Immunotherapy utilization in stage IIIA melanoma: less may be moreFrey A, Kerekes D, Khan S, Tran T, Kluger H, Clune J, Ariyan S, Sznol M, Ishizuka J, Olino K. Immunotherapy utilization in stage IIIA melanoma: less may be more. Frontiers In Oncology 2024, 14: 1336441. PMID: 38380358, PMCID: PMC10876869, DOI: 10.3389/fonc.2024.1336441.
- PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study.Cao D, Yang Z, Dong S, Li Y, Mao Z, Lu Q, Xu P, Shao M, Pan L, Han X, Yuan J, Fan Q, Chen L, Wang Y, Zhu W, Yu W, Wang Y. PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study. BMC Med 2024, 22: 55. PMID: 38317152, DOI: 10.1186/s12916-024-03267-5.
- A pilot study of p53 immunohistochemistry in atypical squamous lesions, using a vulvar scoring systemNiu N, Roy S, Ko C. A pilot study of p53 immunohistochemistry in atypical squamous lesions, using a vulvar scoring system. Journal Of Cutaneous Pathology 2024, 51: 379-386. PMID: 38317537, DOI: 10.1111/cup.14591.
- A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS‐102 in irinotecan‐refractory metastatic colorectal cancer patientsLee V, Parkinson R, Zahurak M, Cope L, Cercek A, Verheul H, Gootjes E, Lenz H, Iqbal S, Jones P, Baylin S, Rami V, Ahuja N, Khoueiry A, Azad N. A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS‐102 in irinotecan‐refractory metastatic colorectal cancer patients. International Journal Of Cancer 2024, 154: 1794-1801. PMID: 38312102, DOI: 10.1002/ijc.34845.
- PD-1H/VISTA mediates immune evasion in acute myeloid leukemiaKim T, Han X, Hu Q, Vandsemb E, Fielder C, Hong J, Kim K, Mason E, Plowman R, Wang J, Wang Q, Zhang J, Badri T, Sanmamed M, Zheng L, Zhang T, Alawa J, Lee S, Zeidan A, Halene S, Pillai M, Chandhok N, Lu J, Xu M, Gore S, Chen L. PD-1H/VISTA mediates immune evasion in acute myeloid leukemia. Journal Of Clinical Investigation 2024, 134 PMID: 38060328, PMCID: PMC10836799, DOI: 10.1172/jci164325.
- Rationale and Design of a of a Phase 2, Double-blind, Placebo-controlled, Randomized Trial Evaluating AMPK-activation by Metformin in Focal Segmental GlomerulosclerosisBarsotti G, Luciano R, Kumar A, Meliambro K, Kakade V, Tokita J, Naik A, Fu J, Peck E, Pell J, Reghuvaran A, Tanvir E, Patel P, Zhang W, Li F, Moeckel G, Perincheri S, Cantley L, Moledina D, Perry-Wilson F, He J, Menon M. Rationale and Design of a of a Phase 2, Double-blind, Placebo-controlled, Randomized Trial Evaluating AMPK-activation by Metformin in Focal Segmental Glomerulosclerosis. Kidney International Reports 2024 DOI: 10.1016/j.ekir.2024.02.006.
- Abstract IA006: Leveraging the extreme selection induced by therapeutic bottlenecks to subvert resistance via identifying evolutionarily-informed targets for orthogonal immunotherapyFisk J, Politi K, Gettinger S, Townsend J. Abstract IA006: Leveraging the extreme selection induced by therapeutic bottlenecks to subvert resistance via identifying evolutionarily-informed targets for orthogonal immunotherapy. Cancer Research 2024, 84: ia006-ia006. DOI: 10.1158/1538-7445.canevol23-ia006.
- Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide(Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Real World ExperienceVarga C, Robinson M, Ehsan H, Roberts D, Dicamillo S, Gupta V, Borden S, Bhutani M, Paul B, Atrash S, Ferreri C, Nooka A, Voorhees P, Joseph N. Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide(Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Real World Experience. Transplantation And Cellular Therapy 2024, 30: s377-s378. DOI: 10.1016/j.jtct.2023.12.528.
- Decoupling sequence and conformational determinants of strong IDP binders to inform therapeutic interventionBogin B, Levine Z. Decoupling sequence and conformational determinants of strong IDP binders to inform therapeutic intervention. Biophysical Journal 2024, 123: 74a. DOI: 10.1016/j.bpj.2023.11.520.
- Current Opinion in HematologyHalene S. Current Opinion in Hematology. Current Opinion In Hematology 2024, 31: 39. DOI: 10.1097/moh.0000000000000799.
- PD-1H/VISTA Agonism Inhibits Host Myeloid Antigen Presenting Cells That Suppresses Acute Graft-Versus-Host Disease without Losing Graft-Versus-Leukemia EffectHu Q, Fielder C, Huh W, Kassim A, Kim T. PD-1H/VISTA Agonism Inhibits Host Myeloid Antigen Presenting Cells That Suppresses Acute Graft-Versus-Host Disease without Losing Graft-Versus-Leukemia Effect. Transplantation And Cellular Therapy 2024, 30: s253. DOI: 10.1016/j.jtct.2023.12.336.
- Evaluating intermediate endpoints (IE) for overall survival (OS) in metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI): An IMDC study.Saliby R, Xie W, Wells J, Saad E, Eid M, Labaki C, Semaan K, Ferrier E, Lemelin A, Suárez C, Ruiz-Morales J, Powles T, Wood L, Ebrahimi H, de Velasco G, Takemura K, Agarwal N, Braun D, Heng D, Choueiri T. Evaluating intermediate endpoints (IE) for overall survival (OS) in metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI): An IMDC study. Journal Of Clinical Oncology 2024, 42: 400-400. DOI: 10.1200/jco.2024.42.4_suppl.400.
- Tumor-infiltrating CD163-positive macrophages and clinical outcomes to first-line nivolumab therapy in patients with advanced clear cell renal cell carcinoma (ccRCC) enrolled in the HCRN GU16-260 trial.El Ahmar N, Matar S, Jegede O, Nabil Laimon Y, Savla V, Bagheri Sheshdeh A, Denize T, Mohanna R, Choueiri T, Catalano P, Braun D, Haas N, Hammers H, Bilen M, Stein M, Sosman J, Wu C, McDermott D, Atkins M, Signoretti S. Tumor-infiltrating CD163-positive macrophages and clinical outcomes to first-line nivolumab therapy in patients with advanced clear cell renal cell carcinoma (ccRCC) enrolled in the HCRN GU16-260 trial. Journal Of Clinical Oncology 2024, 42: 448-448. DOI: 10.1200/jco.2024.42.4_suppl.448.
- Detection of sarcomatoid renal cell carcinoma using plasma cell-free DNA methylation.Semaan K, El Zarif T, Seo J, Eid M, Canniff J, Fortunato B, Savignano H, Davidsohn M, Lakshminarayanan G, Saad E, Saliby R, Bakouny Z, Matar S, Nuzzo P, Berchuck J, Signoretti S, Braun D, Freedman M, Baca S, Choueiri T. Detection of sarcomatoid renal cell carcinoma using plasma cell-free DNA methylation. Journal Of Clinical Oncology 2024, 42: 449-449. DOI: 10.1200/jco.2024.42.4_suppl.449.
- Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.Saad E, Labaki C, Miron B, Park J, Bakouny Z, Nassar A, Saliby R, Semaan K, Eid M, Meli K, Nabil Laimon Y, Geynisman D, Kokate R, Braun D, Signoretti S, McGregor B, Plimack E, Choueiri T, Van Allen E, Zibelman M. Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma. Journal Of Clinical Oncology 2024, 42: 459-459. DOI: 10.1200/jco.2024.42.4_suppl.459.
- Cellular and molecular determinants of limited anti-tumor immunity in chromophobe renal carcinoma (ChRCC).Labaki C, Alchoueiry M, Bi K, Zhang L, Hobeika C, Bakouny Z, El Ahmar N, Matar S, Priolo C, Khabibullin D, Schindler N, Camp S, Saliby R, Saad E, Signoretti S, Van Allen E, Shukla S, Henske E, Choueiri T, Braun D. Cellular and molecular determinants of limited anti-tumor immunity in chromophobe renal carcinoma (ChRCC). Journal Of Clinical Oncology 2024, 42: 476-476. DOI: 10.1200/jco.2024.42.4_suppl.476.
- Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT; HCRN GU 22-587).Serzan M, Jegede O, Bilen M, Braun D, Einstein D, Haas N, Hammers H, King J, Runcie K, Sosman J, Sternberg C, Yang Y, Choueiri T, Signoretti S, Atkins M. Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT; HCRN GU 22-587). Journal Of Clinical Oncology 2024, 42: tps492-tps492. DOI: 10.1200/jco.2024.42.4_suppl.tps492.
- Breaking ground: A new model for dual-phase insulin exocytosisThoduvayil S, Weerakkody J, Ramakrishnan S. Breaking ground: A new model for dual-phase insulin exocytosis. Biophysical Journal 2024, 123: 66a. DOI: 10.1016/j.bpj.2023.11.476.
- Integrated suspended lipid membrane platform: Harnessing amperometric and single-molecule capabilities for deep insights into fusion dynamicsWeerakkody J, Thoduvayil S, Ramakrishnan S. Integrated suspended lipid membrane platform: Harnessing amperometric and single-molecule capabilities for deep insights into fusion dynamics. Biophysical Journal 2024, 123: 380a. DOI: 10.1016/j.bpj.2023.11.2323.
- TDP-43 derived α-helical peptides: A novel strategy to prevent TDP-43 aggregation in neurodegenerative disordersSalaikumaran M, Gopal P. TDP-43 derived α-helical peptides: A novel strategy to prevent TDP-43 aggregation in neurodegenerative disorders. Biophysical Journal 2024, 123: 169a. DOI: 10.1016/j.bpj.2023.11.1123.
- Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic reviewJacobs J, Sharma D, Stephens L, Villalba C, Rinder H, Woo J, Wheeler A, Gerberi D, Goel R, Tormey C, Booth G, Bloch E, Adkins B. Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review. British Journal Of Haematology 2024, 204: 1500-1506. PMID: 38291731, DOI: 10.1111/bjh.19313.
- Opportunities for Improving Biopsy and Non-Biopsy-Based Diagnosis of Celiac DiseaseRobert M, Ciacci C, Lebwohl B. Opportunities for Improving Biopsy and Non-Biopsy-Based Diagnosis of Celiac Disease. Gastroenterology 2024 PMID: 38302007, DOI: 10.1053/j.gastro.2024.01.031.
- Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical RecommendationsHabowski A, Budagavi D, Scherer S, Aurora A, Caligiuri G, Flynn W, Langer E, Brody J, Sears R, Foggetti G, Estape A, Nguyen D, Politi K, Shen X, Hsu D, Peehl D, Kurhanewicz J, Sriram R, Suarez M, Xiao S, Du Y, Li X, Navone N, Labanca E, Willey C. Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations. Cancers 2024, 16: 565. PMID: 38339316, PMCID: PMC10854945, DOI: 10.3390/cancers16030565.
- Rapidly progressive subungual gray-brown melanonychiaEcheandia-Francis C, Nock M, Myung P, Zubek A. Rapidly progressive subungual gray-brown melanonychia. JAAD Case Reports 2024, 44: 113-115. PMID: 38414828, PMCID: PMC10897537, DOI: 10.1016/j.jdcr.2024.01.013.
- EGFR-driven lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth.Kuhlmann-Hogan A, Cordes T, Xu Z, Kuna R, Traina K, Robles-Oteiza C, Ayeni D, Kwong E, Levy S, Globig A, Nobari M, Cheng G, Leibel S, Homer R, Shaw R, Metallo C, Politi K, Kaech S. EGFR-driven lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth. Cancer Discovery 2024, 14: 524-545. PMID: 38241033, DOI: 10.1158/2159-8290.cd-23-0434.
- EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth.Kuhlmann-Hogan A, Cordes T, Xu Z, Kuna R, Traina K, Robles-Oteíza C, Ayeni D, Kwong E, Levy S, Globig A, Nobari M, Cheng G, Leibel S, Homer R, Shaw R, Metallo C, Politi K, Kaech S. EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth. Cancer Discovery 2024, of1-of22. PMID: 38270272, DOI: 10.1158/2159-8290.cd-23-0434.
- Topical trametinib for epidermal and sebaceous nevi in a child with Schimmelpenning‐Feuerstein‐Mims syndromeHaller C, Leszczynska M, Brichta L, Maier E, Riddington I, Choate K, Levy M. Topical trametinib for epidermal and sebaceous nevi in a child with Schimmelpenning‐Feuerstein‐Mims syndrome. Pediatric Dermatology 2024 PMID: 38273779, DOI: 10.1111/pde.15523.
- Extended curettage for tumour-induced osteomalacia in the bone.Okajima K, Kobayashi H, Ito N, Kato H, Ishibashi Y, Zhang L, Tsuda Y, Tanaka S. Extended curettage for tumour-induced osteomalacia in the bone. Jpn J Clin Oncol 2024 PMID: 38266040, DOI: 10.1093/jjco/hyad180.
- Modulation of canonical Wnt signaling regulates peribiliary mesenchymal identity during homeostasis and injurySingh S, Budiman T, Redmond D, Gupta V. Modulation of canonical Wnt signaling regulates peribiliary mesenchymal identity during homeostasis and injury. Hepatology Communications 2024, 8: e0368. PMID: 38251878, PMCID: PMC10805418, DOI: 10.1097/hc9.0000000000000368.
- Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition.Lo Y, Lester S, Ellis I, Lanjewar S, Laurini J, Patel A, Bhattarai A, Ustun B, Harmon B, Kleer C, Ross D, Amin A, Wang Y, Bradley R, Turashvili G, Zeng J, Baum J, Singh K, Hakima L, Harigopal M, Komforti M, Shin S, Abbott S, Jaffer S, Badve S, Khoury T, D'Alfonso T, Ginter P, Collins V, Towne W, Gan Y, Nassar A, Sahin A, Flieder A, Aldrees R, Ngo M, Edema U, Sapna F, Schnitt S, Fineberg S. Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition. Archives Of Pathology & Laboratory Medicine 2024 PMID: 38244086, DOI: 10.5858/arpa.2023-0163-oa.
- The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cellsLiao X, Li W, Zhou H, Rajendran B, Li A, Ren J, Luan Y, Calderwood D, Turk B, Tang W, Liu Y, Wu D. The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cells. Nature Communications 2024, 15: 603. PMID: 38242867, PMCID: PMC10798966, DOI: 10.1038/s41467-024-44885-0.
- In‐person validation of the Ichthyosis Scoring SystemEcheandia‐Francis C, Sun Q, Asch S, Bayart C, Benjamin L, Cipriano S, Craiglow B, Dyer J, Levy M, Lilly E, Newell B, Liang J, Gan G, Deng Y, Paller A, Choate K. In‐person validation of the Ichthyosis Scoring System. Pediatric Dermatology 2024, 41: 247-252. PMID: 38234066, DOI: 10.1111/pde.15508.
- A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulationWang H, Slotabec L, Didik S, Li Z, Leng L, Zhao B, Bucala R, Li J. A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation. Metabolism 2024, 153: 155792. PMID: 38232801, PMCID: PMC10932879, DOI: 10.1016/j.metabol.2024.155792.
- Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse modelWang Y, Cho J, Kastrunes G, Buck A, Razimbaud C, Culhane A, Sun J, Braun D, Choueiri T, Wu C, Jones K, Nguyen Q, Zhu Z, Wei K, Zhu Q, Signoretti S, Freeman G, Hemberg M, Marasco W. Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model. IScience 2024, 27: 108879. PMID: 38327771, PMCID: PMC10847687, DOI: 10.1016/j.isci.2024.108879.
- High-Plex Assessment of Biomarkers in TumorsAung T, Bates K, Rimm D. High-Plex Assessment of Biomarkers in Tumors. Modern Pathology 2024, 37: 100425. PMID: 38219953, DOI: 10.1016/j.modpat.2024.100425.
- The National Association of Medical Examiners Position Paper on the Investigation and Certification of Pediatric Deaths From Environmental NeglectGill J, Christensen E, Dennison E, Ely S, Gilson T, Keyes K, Lear K, Lucas J, Mahar T, Quinton R. The National Association of Medical Examiners Position Paper on the Investigation and Certification of Pediatric Deaths From Environmental Neglect. American Journal Of Forensic Medicine & Pathology 2024, 45: e1-e4. PMID: 38215052, DOI: 10.1097/paf.0000000000000911.